Disparity between cost variation of antibiotics in northern and western India: A cross-sectional study
DOI:
https://doi.org/10.21276/r70f9n57Keywords:
Regional disparity, cost variation of antibiotics, AMR development, prescribingAbstract
Background- About 58% of India’s health expenditure is out of pocket expenditure. There is a wide variation in the cost of different brands of the same generic drug. Prescription of expensive brands of antibiotics contributes to the development of antibiotic resistance. There is literature available on the cost variation and cost ratio of antibiotics but none on the regional disparity.
Materials and Methods- An observational cross-sectional study design was adopted. The study was conducted at the medical stores of Aligarh (Uttar Pradesh) and Mumbai (Maharashtra). The maximum and minimum cost/unit in Rupees (INR) of each antibiotic manufactured by multiple pharmaceutical companies was noted. Furthermore, Cost per daily defined dose (cost/DDD) was calculated for the most expensive and least expensive drug.
Results-
ALIGARH- The highest percent cost variation of 1897.14 and cost ratio of 19.97 was found for Piperacillin 4000mg + Tazobactam 500mg tablets. The least percent cost variation of 48.92 and cost ratio of 1.49 was found for ciprofloxacin 200mg vial.
MUMBAI- The highest cost variation of 3031.05 and cost ratio of 31.31 was found for cefixime 200 mg tablets. The least percent cost variation of 6.43 and cost ratio of 1.06 was found for ciprofloxacin 200 mg vial.
Conclusions- There is disparity in the cost variation and ratio between the two cities Aligarh and Mumbai in this study, which can be attributed to availability of different brands, under a generic group, in the different regions of the country.
Downloads
References
Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: A systematic
review. PLoS Med. 2007;4(9): e283
WHO Global Health Expenditure Atlas; 2014. Available from: http://www.
who.int/health-accounts/atlas2014.pdf
Dinesh Kumar Meena, Jayanti Mathiyan. Cost analysis of different antibiotic
brands available in Indian market with reference to National List of Essential
Medicines. Indian Journal of Community Medicine 2021; 46(1)
Report of the Core-Committee for Revision of National List of Essential
Medicines. November,2015.
Gupta RK, Reddy PS. A calm look on cost analysis of different brands of antiepileptic drug. J MGIMS. 2011; 16(i):64-
Shakeel Ahmad Mir. Cost analysis of different brands of antimicrobial agents
available in India. International Journal of Basic &Clinical Pharmacology 2016;
(1)
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research (IABCR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
